Substituted heterocycles as hset inhibitors
US-2025084074-A1 · Mar 13, 2025 · US
This page is not indexed by search engines while we improve data quality.
Collins Ian patents
Collins Ian is listed as an inventor on 8 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Collins Ian |
| Total patents | 8 |
| First publication | Apr 14, 2015 |
| Latest publication | Mar 13, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2 Pyridyl]Amino]Pyrazine-2-carbonitrile and therapeutic uses thereof
US-11787792-B2 · Oct 17, 2023 · US
5-[[4-[[Morpholin-2-yl]Methylamino]-5-(Trifluoromethyl)-2 Pyridyl]Amino]Pyrazine-2-Carbonitrile and Therapeutic Uses Thereof
US-2021276990-A1 · Sep 9, 2021 · US
5-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2 pyridyl]amino]pyrazine-2-carbonitrile and therapeutic uses thereof
US-10259806-B2 · Apr 16, 2019 · US
5-[[4-[[Morpholin-2-yl]Methylamino]-5-(Trifluoromethyl)-2 Pyridyl]Amino]Pyrazine-2-Carbonitrile and Therapeutic Uses Thereof
US-2018022739-A1 · Jan 25, 2018 · US
Pyrazole derivatives as protein kinase modulators
US-2016250187-A1 · Sep 1, 2016 · US
Pyrazole derivatives as protein kinase modulators
US-9283226-B2 · Mar 15, 2016 · US
Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as protein
US-9006430-B2 · Apr 14, 2015 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Astex Therapeutics Ltd | 4 |
| Cancer Research Tech Ltd | 4 |
| Cancer Res Inst Royal | 2 |
| Cancer Rec Tech Ltd | 2 |
| The Inst Of Cancer Research: Royal Cancer Hospital | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 8 |
| A61P43/00 | 7 |
| A61K31/5377 | 7 |
| A61P35/02 | 6 |
| A61K45/06 | 6 |